Clinical trial
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
NCT02272946 is registered in ClinicalTrials.gov with Priscilla Hsue, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
- Lead sponsor
- Priscilla Hsue, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- December 31, 2021
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, hiv